Nipah Virus New Emerging Zoonotic Disease
Mahmoud, E., Mohamed, N. (2019). Nipah Virus New Emerging Zoonotic Disease. EKB Journal Management System, 23(Issue 1), 115-118. doi: 10.21608/smj.2019.41360
Ekram Abd El-Rahman Mahmoud; Nesma Atef Mohamed. "Nipah Virus New Emerging Zoonotic Disease". EKB Journal Management System, 23, Issue 1, 2019, 115-118. doi: 10.21608/smj.2019.41360
Mahmoud, E., Mohamed, N. (2019). 'Nipah Virus New Emerging Zoonotic Disease', EKB Journal Management System, 23(Issue 1), pp. 115-118. doi: 10.21608/smj.2019.41360
Mahmoud, E., Mohamed, N. Nipah Virus New Emerging Zoonotic Disease. EKB Journal Management System, 2019; 23(Issue 1): 115-118. doi: 10.21608/smj.2019.41360

Nipah Virus New Emerging Zoonotic Disease

Sohag Medical Journal
Article 20, Volume 23, Issue 1, January 2019, Page 115-118  XML
Document Type: Original Article
DOI: 10.21608/smj.2019.41360
View on SCiNiTO View on SCiNiTO
Authors
Ekram Abd El-Rahman Mahmoud; Nesma Atef Mohamed
Department of Medical Microbiology and Immunology,Faculty of Medicine, Sohag University.
Abstract
Nipah virus, a paramyxovirus related to Hendra virus, first emerged in
Malaysia in 1998. It is an emerging zoonosis with the potential to cause significant morbidity and mortality in humans and major economic and public health impacts. Bats are the main reservoir for this virus, which can cause disease in humans and animals. There are currently no effective therapeutics, and supportive care and prevention are the mainstays of management.
References
  1. 1-Giangaspero, M. 2013).Nipah Virus. Trop Med Surg, 1(129), 2.      
    1. Pallister J, Middleton D, Broder CC, Wang LF (2011). Henipavirus vaccine development. J Bioterror Biodef: S1:005.
    2. Lamb RA, Parks GD (2007). Paramyxoviridae: The viruses and their replication. In: Knipe DM, Griffin DE, Lamb RA, Straus SE, Howley PM et al., editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins. pp. 1449-1496.
    3. World Organisation for Animal Health (Office International des Épizooties: OIE) (2009) Nipah (virus encephalitis). Technical Disease Cards, OIE, Paris.
    4. World Health Organization (2009) Nipah virus.Media Center. Fact sheet 262.
    5. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, et al. (2008) Clinical presentation of nipah virus infection in Bangladesh.Clin Infect Dis 46: 977-984.
    6. World Organisation for Animal Health (Office International des Épizooties: OIE) (2010) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, OIE, Paris, Hendra and Nipah virus diseases, Chapter 2.9.6. p. 3-9.
      1. Giangaspero, M. (2013).Nipah Virus. Trop Med Surg, 1(129), 2.
      2. Ang, Brenda SP, Tchoyoson CC Lim, and Linfa Wang."Nipah Virus Infection." Journal of clinical microbiology (2018): JCM-01875.
      3. Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan
      4. SR, Chew NK, Chua KB, Lam SK. 2001. Treatment of acute Nipah
      5. encephalitis with ribavirin. Ann Neurol 49:810 – 813.
      6. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, et al. (2011) A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. SciTransl Med 3: 105ra103.
      7. Nahar N, Mondal UK, Sultana R, Hossain MJ, Khan MS, Gurley ES, OliverasE, Luby SP. 2013. Piloting the use of indigenous methods to prevent
      8. Nipah virus infection by interrupting bats’ access to date palm sap in
      9. Bangladesh. Health PromotInt 28: 378 –386.
      10. Satterfield BA, Dawes BE, Milligan GN. 2016. Status of vaccine research and development of vaccines for Nipah virus. Vaccine 34:2971–2975.
      11. Ang, Brenda SP, Tchoyoson CC Lim, and Linfa Wang."Nipah Virus Infection." Journal of clinical microbiology (2018): JCM-01875

 

 

 

 

 

 

 

 

Statistics
Article View: 178
PDF Download: 24